Spatio-temporal properties of 5-lipoxygenase expression and activation in the brain after focal cerebral ischemia in rats

被引:81
作者
Zhou, Yu
Wei, Er-Qing
Fang, San-Hua
Chu, Li-Sheng
Wang, Meng-Ling
Zhang, Wei-Ping
Yu, Guo-Liang
Ye, Yi-Lu
Lin, Shu-Cai
Chen, Zhong
机构
[1] Zhejiang Univ, Sch Med, Dept Pharmacol, Hangzhou 310031, Peoples R China
[2] Zhejiang Univ, Sch Med, Dept Anat, Hangzhou, Peoples R China
关键词
astrocyte; 5-lipoxygenase; focal cerebral ischemia; leukotrienes; neuron;
D O I
10.1016/j.lfs.2006.05.022
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
The role of 5-lipoxygenase (5-LOX) in brain injury after cerebral ischemia has been reported; however, the spatio-temporal properties of 5-LOX expression and the enzymatic activation are unclear. To determine these properties, we observed post-ischemic 5-LOX changes from 3 h to 14 days after reperfusion in rats with transient focal cerebral ischemia induced by 30 rnin of middle cerebral artery occlusion. We found that the expression of 5-LOX, both mRNA and protein, was increased in the ischemic core 12-24 It after reperfusion, and in the boundary zone adjacent to the ischemic core 7-14 days after reperfusion. The increased 5-LOX was primarily localized in the neurons in the ischemic core at 24 h, but in the proliferated astrocytes in the boundary zone 14 days after reperfusion. As 5-LOX metabolites, the level of cysteinyl-leukotrienes in the ischemic brain was substantially increased 3 h to 24 h, near control at 3 days, and moderately increased again 7 days after reperfusion; whereas the level of LTB4 was increased mildly 3 h but substantially 7-14 days after reperfusion. Thus, we conclude that 5-LOX expression and the enzymatic activity are increased after focal cerebral ischemia, and spatio-temporally involved in neuron injury in the acute phase and astrocyte proliferation in the late phase. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:1645 / 1656
页数:12
相关论文
共 52 条
[1]   Neuroprotective effects of lipoxygenase inhibitors against ischemic injury in rat hippocampal slice cultures [J].
Arai, K ;
Nishiyama, N ;
Matsuki, N ;
Ikegaya, Y .
BRAIN RESEARCH, 2001, 904 (01) :167-172
[2]   Protective effect of the 5-lipoxygenase inhibitor AA-861 on cerebral edema after transient ischemia [J].
Baskaya, MK ;
Hu, YG ;
Donaldson, D ;
Maley, M ;
Rao, AM ;
Prasad, MR ;
Dempsey, RJ .
JOURNAL OF NEUROSURGERY, 1996, 85 (01) :112-116
[3]  
BAUD L, 1987, J IMMUNOL, V138, P1190
[4]   RAT MIDDLE CEREBRAL-ARTERY OCCLUSION - EVALUATION OF THE MODEL AND DEVELOPMENT OF A NEUROLOGIC EXAMINATION [J].
BEDERSON, JB ;
PITTS, LH ;
TSUJI, M ;
NISHIMURA, MC ;
DAVIS, RL ;
BARTKOWSKI, H .
STROKE, 1986, 17 (03) :472-476
[5]   International union of pharmacology - XXXVII. Nomenclature for leukotriene and lipoxin receptors [J].
Brink, C ;
Dahlen, SE ;
Drazen, J ;
Evans, JF ;
Hay, DWP ;
Nicosia, S ;
Serhan, CN ;
Shimizu, T ;
Yokomizo, T .
PHARMACOLOGICAL REVIEWS, 2003, 55 (01) :195-227
[6]  
Brock TG, 1998, BIOCHEM J, V329, P519
[7]   TRANSLOCATION AND LEUKOTRIENE SYNTHETIC CAPACITY OF NUCLEAR 5-LIPOXYGENASE IN RAT BASOPHILIC LEUKEMIA-CELLS AND ALVEOLAR MACROPHAGES [J].
BROCK, TG ;
MCNISH, RW ;
PETERSGOLDEN, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (37) :21652-21658
[8]   Cysteinyl-leukotrienes are released from astrocytes and increase astrocyte proliferation and glial fibrillary acidic protein via cys-LT1 receptors and mitogen-activated protein kinase pathway [J].
Ciccarelli, R ;
D'Alimonte, I ;
Santavenere, C ;
D'Auro, M ;
Ballerini, P ;
Nargi, E ;
Buccella, S ;
Nicosia, S ;
Caciagli, F ;
Di Iorio, P .
EUROPEAN JOURNAL OF NEUROSCIENCE, 2004, 20 (06) :1514-1524
[9]   Production of leukotrienes in a model of focal cerebral ischaemia in the rat [J].
Ciceri, P ;
Rabuffetti, M ;
Monopoli, A ;
Nicosia, S .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 133 (08) :1323-1329
[10]   Ischemic tolerance and endogenous neuroprotection [J].
Dirnagl, U ;
Simon, RP ;
Hallenbeck, JM .
TRENDS IN NEUROSCIENCES, 2003, 26 (05) :248-254